language

Home

Tilmicosin Injection 30%

It is indicated for the treatment of respiratory infections in cattle and sheep associated with Mannheimia haemolytica, Pasteurella spp. and other tilmicosin-susceptible micro-organisms, and for the treatment of ovine mastitis associated with Staphylococcus aureus and Mycoplasma spp. Additional indications include the treatment of interdigital necrobacillosis in cattle.

Category:

Liquid Injection

Email:

thomasyan9733@vip.163.com

Pharmaceuticals:

+86-15230180709

Medical Devices:

+86-18603110901

Request a Quote

Description

产品描述

Product Description
COMPOSITION
Contains per ml:
Tilmicosin base........................................ 300 mg
Solvents ad................................................1 ml
INDICATIONS
It is indicated for the treatment of respiratory infections in cattle and sheep associated with Mannheimia haemolytica, Pasteurella spp. and other tilmicosin-susceptible micro-organisms, and for the treatment of ovine mastitis associated with Staphylococcus aureus and Mycoplasma spp. Additional indications include the treatment of interdigital necrobacillosis in cattle (bovine pododermatitis, foul in the foot) and ovine footrot.
USAGE AND DOSAGE
For subcutaneous injection
Cattle – pneumonia: 1 ml per 30 kg body weight (10 mg/kg).
Cattle – interdigital necrobacillosis: 0.5 ml per 30 kg body weight (5 mg/kg).
Sheep – pneumonia and mastitis: 1 ml per 30 kg body weight (10 mg/kg).
Sheep – footrot: 0.5 ml per 30 kg body weight (5 mg/kg).
CONTRA-INDICATIONS
Administration to equine, porcine or caprine species, or to lambs weighing 15 kg or less.
Administration to cattle producing milk for human consumption.
Do not use in heifers within 60 days of calving.
Do not use together with adrenalin or β-adrenergic antagonists such as propranolol.
WITHDRAWAL TIMES
For meat: Cattle: 60 days.
Sheep: 42 days.
For milk: Sheep: 15 days.
STORAGE PRECAUTIONS
Keep out of reach of children.
Protect from light and store in a cool dry place and below 30℃.

FAQs

What main products does Baotai Pharmaceutical supply?

We provide human finished medicines, veterinary drugs, medical devices & consumables, pharmaceutical production equipment and professional technology transfer services.

Which countries and regions do you mainly export to?

Our business covers Southeast Asia, CIS countries, Africa, Middle East and Latin America, including Philippines, Uzbekistan, Vietnam, Ethiopia and more.

Does your company have international GMP qualification support?

Our team is proficient in EU-GMP and PICS regulations. We hold multiple overseas product registrations and assist factories in passing international GMP audits.

Can you help complete local drug registration in target countries?

Yes. We offer full-set overseas product registration application and approval consulting services for global clients.

What therapeutic areas do your human medicines focus on?

Our medicines mainly cover cardiovascular, antiviral, anti-tumor and other high-standard treatment fields.

Do you cooperate with formal domestic pharmaceutical manufacturers?

We maintain long-term stable partnerships with top Chinese pharmaceutical groups to guarantee product quality and supply stability.